JPH0625164A - Tb toxin - Google Patents
Tb toxinInfo
- Publication number
- JPH0625164A JPH0625164A JP6077891A JP6077891A JPH0625164A JP H0625164 A JPH0625164 A JP H0625164A JP 6077891 A JP6077891 A JP 6077891A JP 6077891 A JP6077891 A JP 6077891A JP H0625164 A JPH0625164 A JP H0625164A
- Authority
- JP
- Japan
- Prior art keywords
- toxin
- soluble
- solvent
- hexane
- methanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は細胞毒性を有する新規化
合物に関する。さらに詳しくは、本発明は下記式TECHNICAL FIELD The present invention relates to a novel compound having cytotoxicity. More specifically, the invention has the formula
【化2】 で表されるTBトキシンに関する。[Chemical 2] TB toxin represented by
【0002】[0002]
【従来の技術】真菌の細胞毒性代謝産物として、サイト
カラシン類やトリコテセン類化合物等が報告されてい
る。しかし、従来報告されている真菌代謝産物中に本発
明のTBトキシンと類似の構造を有するものは知られて
いない。2. Description of the Related Art Cytochalasins, trichothecenes and the like have been reported as fungal cytotoxic metabolites. However, none of the previously reported fungal metabolites having a structure similar to the TB toxin of the present invention is known.
【0003】[0003]
【発明が解決しようとする課題】本発明の目的は、生体
における種々の反応や生体機能を明らかにするための生
化学試薬としてのみならず、医薬として有用な新規化合
物を提供することにある。An object of the present invention is to provide a novel compound useful not only as a biochemical reagent for clarifying various reactions and biological functions in a living body but also as a medicine.
【0004】[0004]
【課題を解決するための手段】本発明者は、鋭意研究の
結果、米を基質として真菌タラロマイセス・バチロスポ
ラス(Talaromyces bacillosporus )NMIC10006株を
培養して得た人工かび米を有機溶媒で抽出し、この抽出
エキスより単離して得られた新規化合物に細胞毒性があ
ることを見出して本発明を完成し、これをTBトキシン
と命名した。[Means for Solving the Problems] As a result of earnest research, the present inventor has extracted artificial fungus rice obtained by culturing the fungus Tlaromyces bacillosporus NMIC10006 strain using rice as a substrate with an organic solvent. The present invention was completed by discovering that the novel compound obtained by isolation from the extract has cytotoxicity, and named it TB toxin.
【0005】尚、本微生物タラロマイセス・バチロスポ
ラスNMIC10006株は千葉県立中央博物館に保管されてお
り、請求により誰にでも入手可能である。[0005] The present microorganism, Talalomyces bacillus polas NMIC10006 strain, is stored in the Chiba Prefectural Central Museum and can be obtained by anyone upon request.
【0006】TBトキシンの製造法について説明する。
真菌タラロマイセス・バチロスポラス NMIC10006株を
米を基質として培養して得た人工かび米を極性の高い溶
媒で抽出した後、非極性溶媒に転溶させ、溶液を減圧乾
燥して抽出エキスを得、この抽出エキスを常法に従いカ
ラムクロマトグラフィーに付し不純物を分離して粗TB
トキシンを得、溶媒から結晶化してTBトキシンを製造
する。A method for producing TB toxin will be described.
Artificial fungus rice obtained by culturing the fungus Talalomyces bacillus polas NMIC10006 strain using rice as a substrate is extracted with a highly polar solvent, then redissolved in a nonpolar solvent, and the solution is dried under reduced pressure to obtain an extract extract. The extract was subjected to column chromatography according to a conventional method to separate impurities to obtain crude TB.
Toxin is obtained and crystallized from solvent to produce TB toxin.
【0007】ここで、抽出用極性溶媒としてはメタノー
ル、アセトニトリルが適し、転溶用非極性溶媒としては
n−ヘキサンが適する。常法によるカラムクロマトグラ
フィーとしては、シリカゲルを充填したカラムを用い
て、クロロホルム−メタノール混液で溶出することによ
り粗TBトキシンを得ることができる。TBトキシンの
結晶化溶媒としてはエタノールが適する。上記のごとく
処理して得られるTBトキシンの物理的及び化学的性質
は次のとおりである。Here, methanol and acetonitrile are suitable as the polar solvent for extraction, and n-hexane is suitable as the nonpolar solvent for transfer. As column chromatography by a conventional method, a crude TB toxin can be obtained by using a column packed with silica gel and eluting with a chloroform-methanol mixture. Ethanol is suitable as a solvent for crystallization of TB toxin. The physical and chemical properties of TB toxin obtained by the treatment as described above are as follows.
【0008】(a) 性 状:淡黄色粉末 (b) 分子量:435(マススペクトルのM+より) (c) 融 点:137〜138℃ (d) 赤外線吸収スペクトル(KBr)(cm-1 )(A) Properties: pale yellow powder (b) Molecular weight: 435 (from M + of mass spectrum) (c) Melting point: 137 to 138 ° C. (d) Infrared absorption spectrum (KBr) (cm -1 )
【図1】参照 νmax:2900、1610、1550、1410、1
120 (e) 核磁気共鳴スペクトル(CDCl3)(ppm) δ:0.88(1H)、1.04(3H)、1.08
(1H)、1.24(2H)、1.27(2H)、1.
33(1H)、1.51(3H)、1.53(1H)、
1.55(3H)、1.61(3H)、1.67(1
H)、1.72(2H)、1.81(1H)、2.08
(2H)、2.15(2H)、2.19(1H)、3.
27(1H)、3.76(1H)、3.97(1H)、
5.26(1H)、6.05(1H)、6.33(1
H)、7.10(1H)、7.48(1H) (f) 呈色反応 リーベルマン・バーチャード反応 陽性(赤
色) ニンヒドリン反応 陰性 (g) 分子式:C28H37NO3 (h) 溶媒に対する溶解性 難溶:水、 可溶:エタノール、n−ヘキサン 易溶:メタノール、アセトン、クロロホルム、ベンゼン1 reference νmax: 2900, 1610, 1550, 1410, 1
120 (e) Nuclear magnetic resonance spectrum (CDCl 3 ) (ppm) δ: 0.88 (1H), 1.04 (3H), 1.08
(1H), 1.24 (2H), 1.27 (2H), 1.
33 (1H), 1.51 (3H), 1.53 (1H),
1.55 (3H), 1.61 (3H), 1.67 (1
H), 1.72 (2H), 1.81 (1H), 2.08
(2H), 2.15 (2H), 2.19 (1H), 3.
27 (1H), 3.76 (1H), 3.97 (1H),
5.26 (1H), 6.05 (1H), 6.33 (1
H), 7.10 (1H), 7.48 (1H) (f) Color reaction Liebermann-Birchard reaction Positive (red) Ninhydrin reaction Negative (g) Molecular formula: C 28 H 37 NO 3 (h) Solvent Solubility: Poorly soluble: water, soluble: ethanol, n-hexane Easy soluble: methanol, acetone, chloroform, benzene
【0009】上記TBトキシンの細胞毒性は以下に示す
実験により確認した。10%の牛胎児血清、10mMの
HEPES緩衝液、6mMのL−グルタミンを含むRP
MI1640培地中、各種濃度のTBトキシンの存在下
ミエローマX63−Ag8−6.5.3細胞あるいは繊
維芽細胞Balb3T3細胞を2日間培養し、その増殖
をMTT法で測定した。これらの細胞の増殖の50%阻
害濃度はいずれも70ng/mlであった。The cytotoxicity of the above TB toxin was confirmed by the following experiments. RP containing 10% fetal bovine serum, 10 mM HEPES buffer, 6 mM L-glutamine
Myeloma X63-Ag8-6.5.3 cells or fibroblast Balb3T3 cells were cultured for 2 days in MI1640 medium in the presence of various concentrations of TB toxin, and the proliferation was measured by the MTT method. The 50% inhibitory concentration of growth of these cells was 70 ng / ml in all cases.
【0010】[0010]
【実施例】次に実施例を挙げて本発明を詳細に説明す
る。 実施例1 10個のフラスコに白米を125gずつとり、オートク
レーブで滅菌し冷却後、滅菌水を40mlずつ加え、真
菌タラロマイセス・バチロスポラス NMIC10006株を接種
し、20日間25℃で培養して人工かび米を得る。この
人工かび米100g当り360mlのメタノール(計4
000ml)でブレンダー中で粉砕しながら抽出し、抽
出液を濾取し、減圧下溶媒を800mlまで濃縮し、n
−ヘキサン1200mlで抽出し、n−ヘキサン層を減
圧下留去し、抽出エキス2.78gを得た。EXAMPLES The present invention will now be described in detail with reference to examples. Example 1 125 g each of white rice was placed in 10 flasks, sterilized in an autoclave and cooled, and then 40 ml of sterilized water was added, inoculated with the fungus Talalomyces batirosporus NMIC10006 strain, and cultured at 25 ° C. for 20 days to give artificial mold rice. obtain. 360 ml of methanol per 100 g of this artificial mold rice (total 4
(000 ml) while pulverizing in a blender, extracting the extract by filtration and concentrating the solvent under reduced pressure to 800 ml,
-Extract with 1200 ml of hexane and evaporate the n-hexane layer under reduced pressure to obtain 2.78 g of the extract.
【0011】この抽出エキスを小量のアセトンに溶解
し、5gのシリカゲル(ワコーゲル−200、和光純薬
製)に吸着させ、溶媒を蒸発除去した後、シリカゲル4
00gを充填したカラムの上に層積し、クロロホルムで
溶出した。TBトキシンを含む溶出液の溶媒を留去して
得た油状物質271.4mgをアセトンに溶解し、0.
1N蓚酸に1分間浸した後110℃12時間乾燥したシ
リカゲル(ワコーゲルC−200、和光純薬製)0.5
gに吸着させ、溶媒を蒸発除去した後、同じく蓚酸処理
したシリカゲル30gを充填したカラムの上に層積し、
クロロホルムで溶出し粗TBトキシン230mgを得
た。これをエタノールで結晶化し、TBトキシン115
mgを得た。その物理的及び化学的性質は下記の通りで
あった。This extract was dissolved in a small amount of acetone, adsorbed on 5 g of silica gel (Wakogel-200, manufactured by Wako Pure Chemical Industries), and the solvent was removed by evaporation, followed by silica gel 4
It was layered on a column packed with 00 g and eluted with chloroform. 271.4 mg of an oily substance obtained by distilling off the solvent of the eluate containing TB toxin was dissolved in acetone, and
Silica gel (Wakogel C-200, manufactured by Wako Pure Chemical Industries, Ltd.) 0.5 which was soaked in 1N oxalic acid for 1 minute and then dried at 110 ° C. for 12 hours
g, and the solvent was removed by evaporation, and then layered on a column packed with 30 g of silica gel also treated with oxalic acid,
Elution with chloroform gave 230 mg of crude TB toxin. This was crystallized with ethanol and TB toxin 115
mg was obtained. Its physical and chemical properties were as follows:
【0012】(a) 性 状:淡黄色粉末 (b) 分子量:435(マススペクトルのM+より) (c) 融 点:137〜138℃ (d) 赤外線吸収スペクトル(KBr)(cm-1 )(A) Property: pale yellow powder (b) Molecular weight: 435 (from M + of mass spectrum) (c) Melting point: 137 to 138 ° C (d) Infrared absorption spectrum (KBr) (cm -1 )
【図1】参照 νmax:2900、1610、1550、1410、1
120 (e) 核磁気共鳴スペクトル(CDCl3)(ppm) δ:0.88(1H)、1.04(3H)、1.08
(1H)、1.24(2H)、1.27(2H)、1.
33(1H)、1.51(3H)、1.53(1H)、
1.55(3H)、1.61(3H)、1.67(1
H)、1.72(2H)、1.81(1H)、2.08
(2H)、2.15(2H)、2.19(1H)、3.
27(1H)、3.76(1H)、3.97(1H)、
5.26(1H)、6.05(1H)、6.33(1
H)、7.10(1H)、7.48(1H) (f) 呈色反応 リーベルマン・バーチャード反応 陽性(赤
色) ニンヒドリン反応 陰性 (g) 分子式:C28H37NO3 (h) 溶媒に対する溶解性 難溶:水、 可溶:エタノール、n−ヘキサン 易溶:メタノール、アセトン、クロロホルム、ベンゼン1 reference νmax: 2900, 1610, 1550, 1410, 1
120 (e) Nuclear magnetic resonance spectrum (CDCl 3 ) (ppm) δ: 0.88 (1H), 1.04 (3H), 1.08
(1H), 1.24 (2H), 1.27 (2H), 1.
33 (1H), 1.51 (3H), 1.53 (1H),
1.55 (3H), 1.61 (3H), 1.67 (1
H), 1.72 (2H), 1.81 (1H), 2.08
(2H), 2.15 (2H), 2.19 (1H), 3.
27 (1H), 3.76 (1H), 3.97 (1H),
5.26 (1H), 6.05 (1H), 6.33 (1
H), 7.10 (1H), 7.48 (1H) (f) Color reaction Liebermann-Birchard reaction Positive (red) Ninhydrin reaction Negative (g) Molecular formula: C 28 H 37 NO 3 (h) Solvent Solubility: Poorly soluble: water, soluble: ethanol, n-hexane Easy soluble: methanol, acetone, chloroform, benzene
【図1】本発明のTBトキシンの赤外線吸収スペクトル
(KBr)を示す図面である。FIG. 1 is a drawing showing an infrared absorption spectrum (KBr) of TB toxin of the present invention.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 上野 芳夫 東京都新宿区市ヶ谷船河原町12 東京理科 大学薬学部内 (72)発明者 小林 公子 埼玉県和光市広沢2−1 理化学研究所内 (72)発明者 堀江 義一 千葉県千葉市青葉955−2 千葉県中央博 物館内 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Yoshio Ueno 12 Ichigaya, Funagawara-cho, Shinjuku-ku, Tokyo Inside the Faculty of Pharmaceutical Sciences, Tokyo University of Science (72) Kimiko Kobayashi 2-1 Hirosawa, Wako City, Saitama Prefecture (72) Inventor Horie Yoshikazu Chiba Chiba City Aoba 955-2 Chiba Prefecture Central Museum Building
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6077891A JPH0625164A (en) | 1991-02-22 | 1991-02-22 | Tb toxin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6077891A JPH0625164A (en) | 1991-02-22 | 1991-02-22 | Tb toxin |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH0625164A true JPH0625164A (en) | 1994-02-01 |
Family
ID=13152090
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP6077891A Pending JPH0625164A (en) | 1991-02-22 | 1991-02-22 | Tb toxin |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0625164A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102532026A (en) * | 2011-11-16 | 2012-07-04 | 云南大学 | Talamidolide compounds and application thereof |
-
1991
- 1991-02-22 JP JP6077891A patent/JPH0625164A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102532026A (en) * | 2011-11-16 | 2012-07-04 | 云南大学 | Talamidolide compounds and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Buechi et al. | Four new mycotoxins of Aspergillus clavatus related to tryptoquivaline | |
JPH05502163A (en) | new product | |
CN115595343A (en) | Active secondary metabolite in cherry tomato rhizosphere soil microorganism and preparation and application thereof | |
CN109020943B (en) | Antituberculous polyketone compound and preparation method and application thereof | |
CN110218200B (en) | Cyclic depsipeptide compound in mangrove endophytic fungi and preparation method and application thereof | |
CN109942658B (en) | Heteroterpene compounds, preparation method and application thereof, and antitumor drugs | |
WO2001064931A1 (en) | Manufacture and purification of mycophenolic acid | |
JPH0341475B2 (en) | ||
JPH0625164A (en) | Tb toxin | |
US4975368A (en) | Novel androst-4-ene-3,17-dione derivatives and method for preparing same | |
CA1109406A (en) | Production of monorden | |
CN105802872B (en) | Pseudomonas fluorescens, method for producing phenazine amide and application thereof | |
CN110872338B (en) | Indole diterpenoid compound and preparation method and application thereof | |
JP2873894B2 (en) | Cyclic depsipeptide and method for producing the same | |
JP2695225B2 (en) | New substance UCT-1003 | |
US3701787A (en) | Preparation of 5,6-dihydro-5-hydroxy-6-propenyl-2-pyrone by fermentation and derivatives thereof | |
JPH11269125A (en) | Cyathane derivative and nerve growth factor production inducer containing the same as active ingredient | |
US5254727A (en) | Acyclic tricarboxylic acid compounds | |
JPH0769961A (en) | Cyathane derivative, and neuro growth factor production inducing agent and antimicrobial agent using the same as active component | |
FR2557455A1 (en) | ANTIBIOTIC NEW 81-484 ANTITUMER AND ITS PRODUCTION | |
KR20020037730A (en) | New iodolocarbazole alkaloids from a marine actinomycete | |
CN108822119B (en) | Erythronolide ketone compound with autophagy activation activity, preparation method and pharmaceutical application thereof | |
US3803307A (en) | Antibiotic sl 21429 | |
JP2734136B2 (en) | Octadecenoic acid derivative and cell killer for cervical cancer cells containing the same as active ingredient | |
JPH0770168A (en) | Cyathane derivative and nerve growth factor production inducer containing the same and antimicrobial agent |